Graft immaturity and safety concerns in transplanted human kidney organoids by Nam, S.A. et al.
Nam et al. Experimental & Molecular Medicine (2019) 51:145
https://doi.org/10.1038/s12276-019-0336-x Experimental & Molecular Medicine
ART ICLE Open Ac ce s s
Graft immaturity and safety concerns in
transplanted human kidney organoids
Sun Ah Nam1,2, Eunjeong Seo1, Jin Won Kim1, Hyung Wook Kim2, Hong Lim Kim3, Kyuryung Kim4,5, Tae-Min Kim4,5,
Ji Hyeon Ju6, Ivan G. Gomez7, Kohei Uchimura8, Benjamin D. Humphreys8, Chul Woo Yang2, Jae Yeon Lee9, Jin Kim1,
Dong Woo Cho 9, Benjamin S. Freedman7 and Yong Kyun Kim1,2
Abstract
For chronic kidney disease, regeneration of lost nephrons with human kidney organoids derived from induced
pluripotent stem (iPS) cells is proposed to be an attractive potential therapeutic option. It remains unclear, however,
whether organoids transplanted into kidneys in vivo would be safe or functional. Here, we purified kidney organoids
and transplanted them beneath the kidney capsules of immunodeficient mice to test their safety and maturity. Kidney
organoid grafts survived for months after transplantation and became vascularized from host mouse endothelial cells.
Nephron-like structures in grafts appeared more mature than kidney organoids in vitro, but remained immature
compared with the neighboring mouse kidney tissue. Ultrastructural analysis revealed filtration barrier-like structures,
capillary lumens, and tubules with brush border in the transplanted kidney organoids, which were more mature than
those of the kidney organoids in vitro but not as organized as adult mammalian kidneys. Immaturity was a common
feature of three separate differentiation protocols by immunofluorescence analysis and single cell RNA sequencing.
Stroma of transplanted kidney organoid grafts were filled with vimentin-positive mesenchymal cells, and
chondrogenesis, cystogenesis, and stromal expansion were observed in the long term. Transcription profiles showed
that long-term maintenance after kidney organoid transplantation induced transcriptomic reprogramming with
prominent suppression of cell-cycle-related genes and upregulation of extracellular matrix organization. Our data
suggest that kidney organoids derived from iPS cells may be transplantable but strategies to improve nephron
differentiation and purity are required before they can be applied in humans as a therapeutic option.
Introduction
Chronic kidney disease (CKD) has emerged as a global
healthcare crisis1. CKD often leads to end-stage renal
disease (ESRD), for which patients require either hemo-
dialysis or kidney transplantation in order to survive.
However, both renal replacement therapies are limited—
the mortality and morbidity rates in patients on dialysis
remain much higher than those in the general population,
while transplantation is limited by the shortage of donor
organs and the need for lifelong immunosuppressive
therapy. Considering the globally increasing prevalence
and annual incidence of CKD, new therapeutic options
are urgently needed.
CKD progression results from a loss of functional
nephrons2. Since new nephrons cannot be generated in
the adult human kidney, the functional nephrons lost
during the progression of CKD cannot be recovered
naturally. Therefore, regenerative medicine, in which the
nephrons lost during CKD progression are replaced using
stem cells, is an attractive potential therapeutic option for
CKD. Recently, we and others have established several
different protocols for the generation of kidney organoids
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from induced pluripotent stem (iPS) cells, containing
segmented structures with podocytes, proximal tubules,
and distal tubules in nephron-like arrangements3–7.
Direct comparisons with kidney tissue in vivo reveals
that kidney organoids formed in vitro remain relatively
immature4. Organoids lack bona fide vasculature, podo-
cyte foot processes, or tubular brush borders, all of which
are essential functional characteristics of the nephron3,4.
Previous studies have shown that kidney organoids or
kidney progenitor cells derived from human PS cells can
be transplanted into mouse kidneys and survive in vivo,
forming grafts that express markers of nephron segments
and recruit vasculature from the host3,6,8–11.
However, it has not been clearly established whether
kidney organoids transplanted into kidneys in vivo are as
mature as adult kidney. As kidney organoid cultures also
contain non-kidney cells (off-target cells), such as neu-
rons, it is important to determine whether these might
also pose a risk of uncontrolled proliferation or
tumorigenesis3,12,13.
In this study, we transplant kidney organoids derived
from iPS cells into mouse kidneys and focused specifically
upon their maturity and safety. Although these organoids
could survive in vivo, and showed some signs of
maturation, the transplanted kidney organoids remained
immature compared with kidney tissue in vivo. Cartilage
formation reminiscent of teratoma tumors was also
observed after long-term follow-up. These findings sug-
gest caution in the application of human kidney organoids
as grafts in patient populations.
Materials and methods
Kidney organoid differentiation
The CMC11 iPSC cell line was obtained from The
Catholic University of Korea (male donor). Cells were
used between passages 30 and 60. Kidney organoid dif-
ferentiation was performed as described previously
(Freedman et al.3). In brief, hPSCs were plated at a density
of 5000 cells/well of a 24-well plate in mTeSR1 medium
(Stem Cell Technologies)+10 µM Y27632 (LC Labora-
tories) on glass plates (LabTek) coated with 3% GelTrex
(Thermo Fisher Scientific) (day −3). The medium was
exchanged for 1.5% GelTrex in mTeSR1 (day −2),
mTeSR1 (day −1), RPMI (Thermo Fisher Scientific)+
12 µM CHIR99021 (Tocris) (day 0), or RPMI+
B27 supplement (Thermo Fisher Scientific) (day 1.5) and
cells were fed every 2–3 days to promote kidney organoid
differentiation. Organoids were fixed or transplanted into
NOD-SCID mice on day 18.
Immunofluorescence and immunohistochemical analysis
For immunofluorescence, organoids were fixed on day
18, unless otherwise noted. For fixation, an equal volume
of PBS (Thermo Fisher Scientific)+ 8% paraformaldehyde
(Electron Microscopy Sciences) was added to the medium
for 15min, after which the sample was washed three times
with PBS. The fixed organoid cultures were blocked in 5%
donkey serum (Millipore)+ 0.3% Triton‐X‐100/PBS, incu-
bated overnight in 3% bovine serum albumin (Sigma)+
PBS with primary antibodies, washed, incubated with
AlexaFluor secondary antibodies (Invitrogen), washed, and
stained with DAPI or mounted in Vectashield H‐1000. For
single post-embedding immunohistochemical staining
(IHC), kidney and kidney organoids were embedded in wax
after fixation and cut transversely at a thickness of 4 μm
using a microtome. Some kidney sections and kidney
organoids section were processed and stained with hema-
toxylin and eosin stain or Masson’s trichrome stain. Other
sections were processed for post-embedding immunohis-
tochemistry analysis. These tissue sections were hydrated
with graded ethanol and rinsed in tap water. After dewax-
ing, the sections were incubated with retrieval solution for
10min by microwave, washed in tap water, and incubated
with methanolic H2O2 for 30min for endogenous perox-
idase blocking. Next, the sections were incubated with 0.5%
Triton X-100/PBS solution for 15min and then rinsed with
PBS. Nonspecific binding sites were blocked with normal
donkey serum (diluted 1:10 in PBS) for 1 h and subse-
quently incubated with primary antibodies overnight at 4 °
C. The next day, after rinsing in PBS, the sections were
incubated for 2 h in peroxidase-conjugated donkey anti-
mouse or anti-rabbit immunoglobulin G (IgG; Jackson
Immuno Research Lab., West Grove, PA, USA) and washed
again with 0.05M Tris buffer (pH 7.6). For detection, the
sections were treated with 0.05% 3,3′-diaminobenzidine
(DAB) and 0.01% H2O2. The sections were washed with
distilled water, dehydrated with graded ethanol and xylene,
mounted in Canada balsam, and examined by light
microscopy.
For multiple post-embedding IHC, tissue and organoid
sections were DAB-stained and then treated with
methanolic H2O2 for 30min to remove any peroxidase
remaining from the first staining. The sections were then
incubated with the other primary antibody. After washing
one time with PBS, the sections were incubated for 2 h
with peroxidase-conjugated donkey anti-rabbit IgG
(Jackson Immuno Research Lab). For detection of per-
oxidase, Vector SG (Vector Laboratories, Burlingame, CA,
USA) was used as a chromogen to produce a grayish blue
color, which is easily distinguished from the brown
staining produced by DAB. The sections were washed
with distilled water, dehydrated with graded ethanol and
xylene, mounted in Canada balsam, and examined by light
microscopy. The following primary antibodies were used:
anti-LTL (Vector Labs FL‐1321, 1:500 dilution), anti-ZO‐
1 (Invitrogen 339100, 1:100), anti-NPHS1 (R&D AF4269,
1:500), anti-ECAD (Abcam ab11512, 1:100), anti-THP
(MP Bio 55140, 1:200), anti-Claudin 1 (Abcam an15098,
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1:100), anti-WT1 (Abcam ab89901, 1:100), anti-CD31
(R&D Systems AF3628, 1:200), anti-laminin (Sigma-
Aldrich L9393, 1:200), anti-human nuclear antibody
(HNA) (Merck Millipore MAB1281, 1:100), and anti-
WT1 (Santa Cruz sc‐192, 1:100).
Electron microscopy (EM) analysis
Adult mouse kidney block samples, samples from the
transplanted kidney organoids and kidney organoid
in vitro samples were fixed in 4% paraformaldehyde and
2.5% glutaraldehyde in 0.1M phosphate buffer overnight
at 4 °C. After washing in 0.1M phosphate buffer, the
samples were postfixed with 1% osmium tetroxide in the
same buffer for 1 h at 4 °C. Next, the samples were
dehydrated with a series of graded ethyl alcohol solutions,
exchanged through acetone, and embedded in Epon 812.
Ultrathin sections (70–80 nm) were obtained by an
ultramicrotome (Leica Ultracut UCT, Germany). The
ultrathin sections were double-stained with uranyl acetate
and lead citrate, after which they were examined under a
transmission electron microscope (JEM 1010, Japan) at
60 kV. For quantitative analysis, 20 low-magnification
(×6000) fields were randomly selected from each section
of the cortex and the number of autophagosomes per
100 μm2 was determined.
Analysis of kidney organoids from alternative
differentiation protocols
Additional kidney organoids were differentiated using
the Morizane or Takasato protocols as described in
ref. 13. Organoids and human adult kidney were fixed in
4% paraformaldehyde (Electron Microscopy Services),
cryoprotected in 30% sucrose solution overnight and
embedded in optimum cutting temperature (OCT)
compound (Tissue Tek). Organoids and kidneys were
cryosectioned at 6 µm thickness and mounted on
Superfrost slides (Thermo Fisher Scientific). Sections
were washed with PBS (three times, 5 min each), then
blocked with 1% bovine serum albumin (Millipore
Sigma), permeabilized with 0.1% Triton X-100 in PBS
and then stained with primary antibody specific for
mouse anti-AQP1 (1:500, Abcam, #ab168387) and
Fluorescein labeled LTL (1:500, Vector Labs, #FL-1321).
Secondary antibodies included Cy3-conjugated (Jackson
ImmunoResearch). Then, sections were stained with
DAPI (4′,6′-diamidino-2-phenylindole) and mounted in
Prolong Gold (Life Technologies). Images were obtained
by confocal microscopy (Nikon C2+ Eclipse; Nikon,
Melville, NY).
Transplantation of kidney organoids derived from human
iPSCs
Adherent organoids were microdissected with a 23-
gauge syringe needle from 24-well plates on an inverted
phase-contrast microscope, after which they were care-
fully transferred using a transfer pipette into an Eppen-
dorf tube containing RB. The harvested kidney organoids
in the Eppendorf tubes were transferred into PE50 tubes
by slow aspiration. The organoids were isolated on day
18 of differentiation. Eight week-aged immunodeficient
male NOD/SCID mice (Jackson Laboratories, West
Grove, PA, USA) were used as hosts for kidney organoid
transplantation. The mice were anesthetized with zoletil,
after which the kidney was exposed via a dorsal flank
incision. After incision of the host kidney capsule at
~2 mm with a 23-gauge syringe needle, a PE50 tube
containing 10–20 kidney organoids was carefully placed
under the kidney capsule. The kidney organoids were
delivered by careful blowing through the other side of
the PE50 tube. Mice were sacrificed at 7, 10, 14, 28, and
42 days after transplantation (n= 3 per each group).
To investigate the transplantation of kidney organoids
into the diseased kidney, we used a UUO model. UUO
was performed as previously described. Briefly, mice
were anesthetized with zoletil and the left ureter was
exposed via a left dorsal incision. The mid-ureter was
then obstructed using a two-point ligation with silk
sutures. Sham-operated mice underwent the same pro-
cedure, except that the ureter was not obstructed, and
used as controls. Kidney organoids were transplanted at
the time of UUO. Mice were sacrificed at 14 days after
UUO. After anesthetization, the animals were perfused
with phosphate buffer (PBS; pH 7.4). Next, they were
fixed with 2% paraformaldehyde-lysine-periodate solu-
tion, which was administered through the heart for
10 min. After perfusion, the kidneys were removed and
cut into 1–2-mm-thick slices, which were further fixed
by immersion in the same fixative overnight at 4 °C. To
examine the effects of kidney decellularized extracellular
matrix (dECM) hydrogel kidney dECM on mal-
differentiation after transplantation we transplanted
kidney organoids with 1% kidney dECM under the
capsule of NOD-SCID mouse kidney simultaneously. All
experimental procedures were performed according to
the Animal Care and Ethics Legislation and the study
was approved by the Animal Care Committee of Seoul
St. Mary’s Hospital.
Decellularization of kidney
Porcine kidney tissue was sliced into 0.1−0.3-mm-
thick slices and washed three times with distilled water
for 30 min. Next, the slices were treated with 0.5% Triton
X-100 (Sigma-Aldrich) in 1M NaCl (Samchun Pure
Chemicals) for 16 h. After then it washed three times
again for 1 h. Treatment with DNase was performed to
ensure removal of residual DNA from the decellularized
tissue. An isotonic 1X phosphate buffered saline was
prepared, and DNase was dissolved to a final
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concentration of 45 U/ml. The tissues were then added
with DNase-containing solution at 37 °C for 6–7 h for to
allow enzymatic treatment within the active period. The
DNase-treated tissue slices were then washed with PBS
for 12 h, followed by sterilization with 0.1% peracetic
acid solution for 1 h and another washing using distilled
water. Decellularized tissues were freeze-dried at −80 °C
and then used for biochemical characterization and
kidney dECM hydrogel preparation.
Microarray experiment
Total RNA was prepared from the kidney organoids
in vitro and the transplanted kidney organoids using
TRIzol (Invitrogen). Gene expression studies were per-
formed using the Affymetrix One Cycle labeling kit. The
data were summarized and normalized with robust
multi-average (RMA) method implemented in Affyme-
trix® Power Tools (APT). We exported the result with
gene level RMA analysis and performed the differentially
expressed gene (DEG) analysis. Statistical significance of
the expression data was determined using LPE test and
fold change in which the null hypothesis was that no
difference exists among groups. False discovery rate
(FDR) was controlled by adjusting p value using
Benjamini-Hochberg algorithm. For expression profiles,
the median absolute deviation was calculated, and highly
variable genes were selected for hierarchical clustering
with average linkage.
Gene set enrichment analysis (GSEA)
For functional gene set-level pathway analysis, GSEA
(software v3.0) was performed using the curated pathway
information from MSigDB (c2cp.v6.2.symbols; 1329 gene
sets; PMID: 16199517). For gene set enrichment analysis,
nominal P values were estimated for 1000 permutations of
genes for each GO category. Gene sets showing a sub-
stantial enrichment (i.e., top 10 gene sets with the highest
normalized enrichment scores) either to in vitro cultured
organoids compared with those transplanted or vice versa.
Other parameter options for the GSEA run include type
of permutation was generated by random gene sets and
collapse data to gene symbols were set to FALSE.
Results
Nephron-like structures engraft and undergo structural
changes after transplantation
We began by developing a protocol to enrich grafts for
nephron-specific cells away from non-kidney con-
taminants (e.g., neurons), which arise naturally in orga-
noid cultures and would be undesirable for
transplantation3,12–14. To accomplish this, we utilized an
adherent culture differentiation protocol in which kidney
organoids form in discrete tubular structures that can be
readily purified by microdissection from the surrounding
stroma3,4,15. We and others have shown that organoids
obtained using this protocol are similar in composition to
those obtained with protocols from other groups12,14–16.
Fig. 1 Transplanted human kidney organoids grow with nephron-like structures over time. a Experimental design. Kidney organoids were
differentiated from human iPS cell by an adherent culture differentiation protocol and were purified by microdissection. The microdissected nephron
structures were subsequently implanted beneath the kidney capsule of immunodeficient NOD-SCID mice. b Representative images of H&E staining
after transplantation. Scale bars, 500 μm. c Representative images of immunohistochemical staining images with HNA after transplantation. Scale
bars, 500 μm.
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The microdissected nephron structures, which are enri-
ched for epithelial cell types, were subsequently implanted
beneath the kidney capsule of immunodeficient NOD-
SCID mice for engraftment (Fig. 1a).
During the following two weeks, the tubular structures in
the transplanted kidney organoids appeared to grow
modestly in length and width over time, and stromal cells
also expanded greatly during this time period (Fig. 1b).
Human nuclear antigen (HNA) was expressed in the kid-
ney organoid graft, but not in host mouse kidney (Fig. 1c).
Immunofluorescence analysis revealed that cells expressing
markers of podocytes (NPHS1), parietal epithelial cells or
PECs (claudin-1), proximal tubular cells (Lotus tetra-
gonolobus lectin or LTL), and distal tubules (ECAD) in the
transplanted kidney organoids originated from the iPS cells,
not from the host mouse kidneys (Fig. 2a, b).
We examined the structural changes of nephron-like
structures after transplantation. In glomerulus-like
structures, Bowman’s spaces were expanded after trans-
plantation, compared with those of the kidney organoids
in vitro (Supplementary Fig. S1A, B). In tubule-like
structures, luminal spaces were greater in diameter than
those of the kidney organoids in vitro (Supplementary Fig.
S1C, D).
During kidney development, paired box 2 (Pax2) is
expressed in the nephric duct, the mesonephric tubules,
and in the metanephric mesenchyme, and is an important
regulator of nephron differentiation17,18. As the nephron
mature, Pax2 is downregulated first in the podocyte
progenitor cells and subsequently in all proximal and
distal tubules of the nephron18,19. In adulthood, very few
renal differentiated cells maintain Pax2 expression19. We
found that PAX2 was expressed in tubule-like structures
and parietal epithelial cell-like structures in kidney orga-
noid grafts, similar to kidney organoids in vitro (Fig. 2c),
indicating that the nephron-like tubules in the trans-
planted kidney organoids graft remained immature. As an
internal control, we confirmed that PAX2 was down-
regulated in adjacent NPHS1-positive podocytes within
the graft (Fig. 2c), just as we have previously shown it to
be downregulated in organoid podocytes in vitro4. Taken
together, these findings indicate that transplantation into
the host kidneys produces changes in the structure of
nephron compartments in kidney organoids derived from
iPS cells, but did not induce a complete maturation of
the cells.
Transplanted kidney organoids are infiltrated by
endothelial cells
Vascularization is crucial for nephron maturation in
kidney development. Furthermore, the vascularization of
kidney metanephric grafts after transplantation is
important for survival and successful engraftment20.
Therefore, we investigated the extent of vascularization of
the transplanted kidney organoids and the origin of the
endothelial cells in the transplanted kidney organoids. We
could observe human endothelial cells derived from the
transplanted kidney organoids (CD31+/HNA+), but their
proportion of the endothelial cells in the graft was small
(Fig. 3a, b). Mouse endothelial cells (MECA32+) were
Fig. 2 Expression of renal epithelial and progenitor cell markers
in transplanted kidney organoids. a Representative confocal
fluorescence images showing podocyte (NPHS1) and parietal
epithelial cell (Claudin 1) populations in the transplanted kidney
organoids. Scale bars, 50 μm. b Representative confocal fluorescence
images showing proximal tubules (LTL) and distal tubules (E-cadherin)
in the transplanted kidney organoids. c Representative confocal
fluorescence images showing the renal progenitor cell marker, Pax2.
Scale bars, 50 μm.
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abundantly observed in the transplanted kidney organoid
graft as well as within the glomerulus-like structures
(Fig. 3c), which indicates that endothelial cells from the
host mouse kidney had extensively infiltrated into the
transplanted kidney organoids and formed a vascular
network.
The glomerular basement membrane (GBM) is essential
for filtering the blood during urine production in the
mammalian kidney21,22. Therefore we examined whether
the infiltrated mouse endothelial cells express markers of
GBM in the transplanted kidney organoids. The mouse
endothelial cells in glomerulus-like structures co-localized
with laminin, an extracellular matrix component of GBM
(Fig. 3d). This suggested that a GBM-like structure may
be forming in the grafts at the interface between endo-
thelial cells and podocytes.
Ultrastructure of podocytes and tubules reveals partial
graft maturation
We further analyzed these structures by transmission
electron microscopy (TEM) to determine the cellular
ultrastructure of the podocytes and tubules, and com-
pared kidney organoids in vitro, transplanted kidney
organoids, and adult mouse kidney. First, to identify the
sections containing the glomerular and tubular-like
structures (Fig. 4a) from the transplanted kidney orga-
noids, toluidine blue staining was performed and sections
were cut under light microscopy.
In the kidney organoids in vitro, the podocytes had
apical microvilli and were arranged intermittently along
poorly organized GBM‐like tracks (Fig. 4b). In contrast
to these structures, red blood cell fragments were
observed in the transplanted kidney organoids, sugges-
tive of possible capillary formation (Fig. 4b). The podo-
cytes in the transplanted kidney organoids looked similar
to the organoids in vitro and direct comparison to adult
kidney demonstrated that organoids lacked bona fide
foot processes with well-organized tertiary interdigita-
tions along the GBM (Fig. 4b). Glomerulus-like struc-
tures were surrounded by a tubular epithelium with
Fig. 3 Transplanted kidney organoids are vascularized with
infiltrating endothelial cells from the host kidney and form GBM-
like structures. a Representative confocal images of transplanted
kidney organoids at 14 days after transplantation. White arrow in the
enlarged images indicate CD-31-positive, HNA-positive cells and open
arrow indicate CD-31-positive, HNA-negative cells. Scale bars, 50 μm.
b Quantification of CD31+/HNA+ cells and CD31+/HNA− cells of the
CD31+ cells. c Representative confocal images of podocytes (NPHS1)
and mouse endothelial cells (MECA32) in the transplanted kidney
organoids at 14 days after transplantation. Scale bars, 50 μm.
d Representative confocal images of glomerular-like structures in the
transplanted kidney organoids. Cells were stained for NPHS1, MECA32
and laminin. Scale bars, 50 μm.
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intervening space, similar in architecture to a Bowman’s
capsule but with a substantially thicker capsular layer
(Fig. 4a, b).
Interestingly, the tubules in the transplanted kidney
organoids exhibited brush borders similar to the prox-
imal tubules of the adult mouse kidney; these borders
were rarely observed in the kidney organoids in vitro
(Fig. 4c). The length of brush borders, however, was
shorter than that of adult mouse kidney (Fig. 4c, d).
Taken together, these findings suggest that the matura-
tion of nephron-like structures in the transplanted kidney
organoids was incomplete.
Aquaporin-1 expression in organoids is low
The water channel aquaporin-1 (AQP1) is strongly
expressed in kidney proximal tubules. However, we
observed AQP1 to be largely absent in kidney organoid
tubules in vitro, indicating these structures were not fully
differentiated (Fig. 5a). In grafts, we found that AQP1
expression was likewise negligible in the human tubules
(Fig. 5a). In contrast, AQP1 was robustly detected in the
neighboring mouse kidney tubules, and in human kidney
tissue, with same antibody (Fig. 5a).
To test whether this was a deficiency in our particular
differentiation protocol, we further examined the
expression of AQP1 in kidney organoids differentiated by
two different (alternative) protocols5,7. Single cell tran-
scriptomic analyses data revealed negligible expression of
AQP1 in kidney organoid tubules differentiated by both of
the alternative protocols (Fig. 5b)13. In contrast, LRP2
(megalin) was readily detected in tubular cells in these
same datasets (Fig. 5b). Immunofluorescence analysis of
proximal tubules from both of the other protocols also
demonstrated negligible signal for AQP1, compared with
sections of kidney tissue in vivo (Fig. 5c). Thus these
organoids resembled our own. Binding of LTL was also
reduced compared with tissue sections, but was never-
theless readily detected (Fig. 5c). Similar results were
obtained with two additional batches of these organoids
derived using the two alternative protocols (Supplemen-
tary Fig. S2). Artificially brightening the organoid images
strengthened the LTL signal and suggested a possible faint
signal for AQP1, but this remained substantially lower
than in the images of kidney tissue, which when similarly
brightened appeared severely overexposed. These findings
demonstrate that lack of AQP1 is a general property of
organoids differentiated using three different protocols
currently in common use, suggests that the proximal
tubules derived using these protocols are similar in
composition, and indicates that all of these protocols
generate organoids that are immature compared with
those in vivo.
Organoid grafts are progressively overgrown by stromal
cells
The transplanted kidney organoids exhibited excessive
growth of stromal cells, which expressed vimentin, a
mesenchymal cell marker, similar to postnatal mouse
kidney, whereas interstitial cells of adult mouse kidney
were negative for vimentin (Fig. 6a). The tubules and
PECs-like structures in the kidney organoids also
showed partial staining for vimentin (Fig. 6a), which
resembled the pattern of vimentin expression in mouse
Fig. 4 The ultrastructure of glomerulus-like structures and
tubules in transplanted kidney organoids remains immature
compared with adult mouse kidneys. a Representative images of
toluidine blue staining. b, c Representative TEM images of kidney
organoids in vitro, the transplanted kidney organoids and adult
mouse kidney. Magnified portions of the images are shown below the
images. P; podocytes. Scale bars, 1 μm. d Quantification of the length
of brush borders (n= 3, kidney organoids in vitro vs. transplanted
kidney organoids vs. adult mouse kidney. *p < 0.05).
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kidney with postnatal day 1, whereas the tubules and
PECs in adult mouse kidney were negative for vimentin
staining (Fig. 6a). The persistence of vimentin in these
structures suggested that maturation of nephron-like
structures is not complete in the transplanted kidney
organoids23–25.
To examine whether the vimentin-positive cells in the
stroma and nephron-like structures originate from human
kidney organoids or host mouse kidney, we stained
vimentin and HNA simultaneously. The vast majority of
vimentin-positive cells expressed HNA (Fig. 6b). We also
replated purified kidney organoids onto glass plates
coated with 3% GelTrex and stained vimentin on orga-
noid outgrowth cells in vitro 7 days after plating (Sup-
plementary Fig. S3)15. Abundant organoid outgrowth cells
expressed vimentin (Fig. 6c, Supplementary Fig. S3).
These findings suggest that the vimentin-positive cells in
the stroma in these grafts derive from outgrowth cells of
the transplanted kidney organoids.
Kidney organoids are transplantable into mouse kidneys
with unilateral ureteral obstruction
Adding nephrons to diseased kidneys with nephron loss
may in the future be an effective therapeutic option. Thus,
to investigate whether the transplanted kidney organoids
survive and vascularize in the setting of kidney disease, we
performed kidney organoid transplantation using a mouse
model of unilateral ureteral obstruction (UUO), which
exhibits progressive tubulointerstitial fibrosis26. The
transplanted kidney organoids were vascularized and
survived in the transplanted graft at 2 weeks after UUO
and transplantation (Fig. 7a).
Interestingly, few fibrotic cells expressing smooth
muscle alpha actin (SMA) were observed in the trans-
planted kidney organoid grafts, whereas the neighboring
mouse kidney tissue with UUO had widespread tubu-
lointerstitial fibrotic lesions (Fig. 7a). Thus, the grafts did
not manifest phenotypic hallmarks of kidney disease
observed in the neighboring kidney. Collectively, these
studies suggest that engraftment of organoids is possible
in settings of renal disease, and that grafts placed beneath
the kidney capsule may be partially protected from
damage to the adjacent kidney.
Chondrogenesis and cyst formation with degenerated
nephron-like structures in long-term follow-up
The transplanted kidney organoids survived until at
least 6 weeks after transplantation. In the absence of
UUO, cartilage formation was observed in the trans-
planted kidney organoid grafts at 4 weeks after trans-
plantation (Fig. 7b). HNA was expressed in the
cartilaginous masses in the transplanted kidney orga-
noids (Fig. 7c). The cartilage became enlarged at 6 weeks
after transplantation (Fig. 7b, d, Supplementary Fig. S4).
Fewer nephron-like structures were observed, and cysts
were formed at 4 weeks and gradually increased in size at
6 weeks after transplantation (Fig. 7b, e). The nephron-
like structures appeared to be degenerated 4 weeks after
Fig. 5 Aquaporin-1 expression is negligible in kidney organoids from different protocols. a Representative confocal fluorescence images of
AQP1; M, mouse kidney; H, human graft. Scale bars, 100 μm. b t-SNE dot plots showing clusters of kidney organoid cells generated using either the
Takasato (T, top) or Morizane (M, bottom) method, analyzed by single cell RNA-seq. c Confocal optical sections of organoids derived using these
protocols or human kidney tissue, using identical laser power and gain settings for AQP1 and LTL channels. Images are representative of three
different batches of organoids for each protocol. Scale bars, 50 µm.
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transplantation and well-organized nephron-like struc-
tures were rarely observed at 6 weeks after transplan-
tation (Fig. 7b). The presence of human cartilage inside
these grafts, interspersed with the human organoid-
derived mesenchyme, suggests that the cells initially
transplanted included non-kidney or partially differentiated
cells, even though the organoids were purified prior to
transplantation. Such contaminants could pose a safety
concern in humans receiving kidney organoid grafts.
Kidney decellularized extracellular matrix (dECM)
hydrogel contains ECM protein such as collagen-IV,
laminin, and heparan sulfate proteoglycan, and provides a
microenvironment similar to normal kidney27. To deter-
mine the role of microenvironment provided from kidney
dECM, we transplanted kidney organoids together with
kidney dECM. We found that cartilage formation in the
group transplanted with kidney dECM was decreased
compared with the group transplanted with kidney
organoids only (Supplementary Fig. S5), which suggest
that maldifferentiation after kidney organoids transplan-
tation may be corrected by adjustment of microenviron-
ment components provided by kidney dECM.
Altered gene expression after transplantation of kidney
organoids with long-term follow-up
To determine the alteration of gene expression in the
transplanted kidney organoids after long-term follow-up,
we examined the transcriptional profiles of the trans-
planted kidney organoids (6 weeks after transplantation),
compared with those of kidney organoids in vitro (day 18).
Hierarchical clustering of highly variable genes clearly
segregated the transplanted kidney organoids and kidney
organoids in vitro (Fig. 8a), indicating a substantial dif-
ference in transcriptomes.
Gene set enrichment analysis was performed to identify
the candidate molecular functions associated with these
transcriptomic changes. Overall, 29 and 353 GO cate-
gories exhibited significant enrichment with upregulated
and downregulated genes, respectively, in the trans-
planted kidney organoids compared with kidney orga-
noids in vitro. Top 10 gene curated canonical pathway
(MSigDB c2cp) terms enriched were shown in Fig. 8b. Of
note, among GO categories downregulated in the trans-
planted kidney organoids, genes for “cell-cycle” and rela-
ted functions (e.g., “cell cycle mitotic” and “DNA
replication”) were significantly enriched. The enrichment
plot of 253 genes from “cell-cycle”-related gene sets is
shown with the top 20 leading-edge genes (Fig. 8c, Sup-
plementary Table S1). In addition, among the GO cate-
gories upregulated in the transplanted kidney organoids,
extracellular matrix organization-related GO function was
observed (Fig. 8b, d), which is consistent with the
expansion of stromal cells and cartilage in the trans-
planted kidney organoids. The enrichment plot of 47
genes from “extracellular matrix organization”-related
gene sets is shown with the top 20 leading-edge genes
(Fig. 8d, Supplementary Table S2). Taken together, these
results from the transcription profiles indicate that long-
term maintenance after kidney organoids transplantation
may induce transcriptomic reprogramming with promi-
nent suppression of cell-cycle-related genes and upregu-
lation of extracellular matrix organization.
Fig. 6 Nephron-like structures in kidney organoid grafts are not
fully mature. a Representative immunohistochemical staining images
showing vimentin staining in transplanted kidney organoids
harvested at 14 days after transplantation, mouse kidneys with
postnatal day 1 and adult mouse kidneys. Magnified portions of the
images are shown to the right of the images. White arrows indicate
parietal epithelial cells and black arrows indicate tubules. Scale bars,
50 μm. b Representative confocal images of HNA and vimentin in the
transplanted kidney organoids at 14 days after transplantation. Scale
bars, 50 μm. c Representative confocal images of vimentin in kidney
organoid outgrowth cells 7 days after transfer onto glass plates coated
with 3% GelTrex. Scale bars, 200 μm.
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Discussion
Adding functional nephrons derived from hPSCs is a
potentially attractive therapeutic option for kidney disease
with nephron loss, but is also fraught with concerns over
safety and efficacy. Thus, it is essential to determine the
maturity of the transplanted organoids and their capacity
for maldifferentiation.
Some recent reports describe in detail vascularization of
human kidney organoid grafts beneath the kidney capsule
and suggest increased maturity of these structures8–12.
Sharmin et al. first reported that the glomeruli in the
transplanted spheres with human iPSC-derived nephron
progenitors were vascularized with host mouse endothe-
lial cells with further maturation although the capillary
loops were rarely formed8. van den Berg et al. also showed
that transplanted kidney organoids derived from hPSCs
have the matured glomerular filtration barrier and tubular
epithelium with host mouse-derived vascularization9.
However, it is still needed to define the maturation stage
in accordance with mammalian kidney development and
find evidence for safety after long-term follow-up.
We also observe some vascularization of podocytes and
maturation in tubules in our grafts similar with previous
studies8–12. However, podocytes do not appear to form
fully mature foot processes, and instead are decorated by
apical microvilli, which are distinct structures4. We also
present the evidence that these still lack fully mature
features such as aquaporin-1 expression, compared with
neighboring mouse kidney tissue. In addition, we report
maldifferentiation in the transplanted graft with the for-
mation of cartilage and cysts of increased-size after long-
term follow-up.
Fig. 7 Kidney organoids are transplantable into mouse kidneys with unilateral ureteral obstruction. a Representative images of Trichrome
staining, and immunohistochemical staining for α-SMA are shown. Cells were stained at 7 days after UUO. Scale bars, 100 μm. A zoom image shows
few α-SMA positive cells in the grafts, whereas they were abundantly expressed in the neighboring mouse kidney tissue with UUO. Scale bar, 30 μm.
b Representative images of H&E staining and immunohistochemical staining for safranin O. Arrows indicate cartilages and an arrow head indicate a
cyst. Scale bars, 500 μm. c Representative images of immunohistochemical staining for HNA. Scale bars, 100 μm. Quantification of the length of
cartilages (d) and cysts (e) (n= 3, 2 weeks vs. 4 weeks vs. 6 weeks after kidney organoids transplantation. *p < 0.05).
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Many of the cells of the transplanted kidney organoid
graft were vimentin-positive mesenchymal cells, which
may differentiate into non-renal cells such as chon-
drocyte, adipocytes or osteocyte28. We have shown pre-
viously that kidney organoids are contaminated by non-
kidney cell types, including neuronal, endothelial, and
muscle cells, as well as rare undifferentiated pluripotent
stem cells3,14. We have recently confirmed the presence of
non-kidney contaminants in two other protocols for
kidney organoid differentiation (Morizane’s protocol and
Takasato’s protocol)13. Our own side-by-side compar-
isons of our differentiation protocol and those of another
lab also suggest that these produce very similar types of
structures14,15.
In this study, we attempted to avoid non-kidney con-
taminants by purifying epithelial organoid structures away
from surrounding stroma by microdissection. Never-
theless, cartilage formation and stromal expansion were
commonplace in these organoid cultures, suggesting
either the persistence of these contaminants or de-
differentiation of epithelia into non-kidney lineages.
This highlights the importance of improving organoid
differentiation protocols to promote definitive differ-
entiation and remove all contaminants, which could
potentially form tumors at the graft site. Our experiments
were performed in NOD-SCID animals which have
minimal immune function and cannot reject xenogeneic
implants. The stromal cells as well as cartilage appeared to
be human based on antibody immunofluorescence and
immunohistochemistry. Importantly, to reduce mal-
differentiation, we transplanted kidney organoids with
kidney decellularized extracellular matrix (dECM)
hydrogel and observed a decrease in cartilage formation.
These data suggest an approach for improvement of
maldifferentiation after kidney organoids transplantation
by adjustment of the graft microenvironment.
Maturational stage of kidney organoids may differ
somewhat among the research groups because of dif-
ferent cell composition in kidney organoids according to
protocols and inter-experimental and inter-clonal
Fig. 8 Altered gene expression after transplantation of kidney organoids with long-term follow-up. a Hierarchical clustering of 1000 variable
probes (median absolute deviation >0.04). b Top 10 gene curated canonical pathway (MSigDB c2cp) terms enriched. Gene set enrichment plot of
GSEA with significant downregulation (c) and upregulation (d) in the transplanted kidney organoids.
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transcriptional variation in kidney organoid differentia-
tion even with the same protocol13,29. This variability
between kidney organoids may produce slightly different
maturational stages after transplantation among the
research groups. For this concern, we demonstrate that
immaturity of organoids in vitro to be a common feature
of three distinct differentiation protocols, as illustrated
by the lack of substantial AQP1 expression in proximal
tubules. This argues against any particular protocol
being substantially more advanced than any other. Fur-
thermore, we have validated the maturational state of
podocytes in kidney organoids differentiated by our
protocol4. Comparative analysis of hPSC-podocytes in
kidney organoids in vitro and developing mammalian
kidney revealed that hPSC-podocytes phenocopied
mammalian podocytes at the capillary loop stage4, which
is similar to the developmental stage of kidney organoids
from other research groups. Our detailed analysis of
AQP1 expression in organoids derived using three dis-
tinct protocols (Freedman, Morizane, and Takasato)
reveals that none of these methodologies yields robust
expression of this classic proximal tubular marker, and
all are therefore immature compared with kidney tissue
in vivo. An advanced protocol to improve the maturation
of kidney organoids in vitro may contribute to enhance
the maturation of kidney organoids after transplantation
and utilize kidney organoids as regenerative medicine for
kidney disease. In conclusion, the transplanted kidney
organoids derived from human iPSCs were partially
vascularized from host mouse endothelial cells and
exhibited signs of increased maturity, compared with
kidney organoids in vitro. However, the maturational
stage of both tubules and podocytes in the transplanted
kidney organoids remained incomplete, and a significant
population of the cells in the grafts formed stromal
growths containing non-kidney cells. Strategies for
overcoming the immaturity and maldifferentiation of the
kidney organoids derived from iPSCs are needed before
attempting transplantation of the kidney organoids into
humans as a therapeutic option for nephron loss30.
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